119 related articles for article (PubMed ID: 26807246)
41. CCND1 G870A polymorphism and colorectal cancer risk: An updated meta-analysis.
Xu XM; Ni XB; Yang GL; Luo ZG; Niu YM; Shen M
Mol Clin Oncol; 2016 Jun; 4(6):1078-1084. PubMed ID: 27284448
[TBL] [Abstract][Full Text] [Related]
42. Current evidence on associations between the MMP-7 (-181A>G) polymorphism and digestive system cancer risk.
Ke P; Wu ZD; Wen HS; Ying MX; Long HC; Qing LG
Asian Pac J Cancer Prev; 2013; 14(4):2269-72. PubMed ID: 23725125
[TBL] [Abstract][Full Text] [Related]
43. Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis.
Lv MQ; Wang J; Yu XQ; Hong HH; Ren WJ; Ge P; Zhou DX
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():12-20. PubMed ID: 28926725
[TBL] [Abstract][Full Text] [Related]
44. Lack of association of tumor necrosis factor superfamily member 4 (TNFSF4) gene polymorphisms (rs3850641 and rs17568) with coronary heart disease and stroke: A systematic review and meta-analysis.
Lu JS; Wang H; Yuan FF; Wu LL; Wang B; Ye DQ
Anatol J Cardiol; 2018 Feb; 19(2):86-93. PubMed ID: 29424751
[TBL] [Abstract][Full Text] [Related]
45. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis.
Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W
Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061
[TBL] [Abstract][Full Text] [Related]
46. Cyclooxygenase-2 polymorphisms and bladder cancer risk: a meta-analysis based on case-control studies.
Wan GX; Chen P; Yu XJ; Di QS; Yu YD; Lei JH; Tai YY; Cao FJ
Int J Clin Exp Med; 2015; 8(3):3935-45. PubMed ID: 26064295
[TBL] [Abstract][Full Text] [Related]
47. Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development.
Mesic A; Rogar M; Hudler P; Bilalovic N; Eminovic I; Komel R
BMC Cancer; 2019 Sep; 19(1):919. PubMed ID: 31521144
[TBL] [Abstract][Full Text] [Related]
48. A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD.
Zhang Y; Piao X; Wu J; Li Y; Liang Q
Int J Neurosci; 2016; 126(5):400-7. PubMed ID: 26000819
[TBL] [Abstract][Full Text] [Related]
49. Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis.
Zhang K; Zhang L; Zhou J; Hao Z; Fan S; Yang C; Liang C
Onco Targets Ther; 2016; 9():567-77. PubMed ID: 26869801
[TBL] [Abstract][Full Text] [Related]
50. Roles of UGT1A1 Gly71Arg and TATA promoter polymorphisms in neonatal hyperbilirubinemia: A meta-analysis.
Wang J; Yin J; Xue M; Lyu J; Wan Y
Gene; 2020 Apr; 736():144409. PubMed ID: 32007587
[TBL] [Abstract][Full Text] [Related]
51. Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis.
Qian K; Xu J; Wan H; Fu F; Lu J; Lin Z; Liu Z; Liu H
Gene; 2015 Sep; 569(2):173-81. PubMed ID: 26071134
[TBL] [Abstract][Full Text] [Related]
52. Myeloperoxidase G-463A polymorphism and susceptibility to coronary artery disease: a meta-analysis.
Tang N; Wang Y; Mei Q
Gene; 2013 Jul; 523(2):152-7. PubMed ID: 23583798
[TBL] [Abstract][Full Text] [Related]
53. C-reactive Protein -717A>G and -286C>T>A Gene Polymorphism and Ischemic Stroke.
Liu Y; Geng PL; Yan FQ; Chen T; Wang W; Tang XD; Zheng JC; Wu WP; Wang ZF
Chin Med J (Engl); 2015 Jun; 128(12):1666-70. PubMed ID: 26063371
[TBL] [Abstract][Full Text] [Related]
54. Association between RAD51 polymorphisms and susceptibility of head and neck cancer: a meta-analysis.
Kong F; Wu J; Hu L; Du Y; Pan Y
Int J Clin Exp Med; 2015; 8(4):6412-9. PubMed ID: 26131267
[TBL] [Abstract][Full Text] [Related]
55. GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis.
Kong X; Li Z; Li X
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1163-1173. PubMed ID: 27785604
[TBL] [Abstract][Full Text] [Related]
56. Correlation between XRCC1 Arg399Gln genetic polymorphisms and susceptibility to bladder cancer: a meta-analysis.
Liu N; Fei X; Shen Y; Shi W; Ma J
Onco Targets Ther; 2016; 9():579-86. PubMed ID: 26869802
[TBL] [Abstract][Full Text] [Related]
57. Associations between two common single nucleotide polymorphisms (rs2241766 and rs1501299) of ADIPOQ gene and coronary artery disease in type 2 diabetic patients: a systematic review and meta-analysis.
Zhao N; Li N; Zhang S; Ma Q; Ma C; Yang X; Yin J; Zhang R; Li J; Yang X; Cui T
Oncotarget; 2017 Aug; 8(31):51994-52005. PubMed ID: 28881706
[TBL] [Abstract][Full Text] [Related]
58. N-acetyltransferase 2 gene polymorphisms are associated with susceptibility to cancer: a meta-analysis.
Tian FS; Shen L; Ren YW; Zhang Y; Yin ZH; Zhou BS
Asian Pac J Cancer Prev; 2014; 15(14):5621-6. PubMed ID: 25081676
[TBL] [Abstract][Full Text] [Related]
59. Single Nucleotide Polymorphisms in
Li X; Li X; Jiang M; Tian W; Zhou B
Front Oncol; 2018; 8():613. PubMed ID: 30619753
[No Abstract] [Full Text] [Related]
60. Polymorphism of fucosyltransferase 3 gene is associated with inflammatory bowel disease: a systematic review.
Zheng J; Zhu T
Asian Biomed (Res Rev News); 2023 Apr; 17(2):45-54. PubMed ID: 37719320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]